Sequoia Financial Advisors LLC Sells 14,063 Shares of Cigna Group $CI

Sequoia Financial Advisors LLC lessened its position in shares of Cigna Group (NYSE:CIFree Report) by 57.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,529 shares of the health services provider’s stock after selling 14,063 shares during the period. Sequoia Financial Advisors LLC’s holdings in Cigna Group were worth $2,808,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in CI. Norges Bank purchased a new stake in Cigna Group in the 4th quarter worth about $1,019,790,000. Northwestern Mutual Wealth Management Co. boosted its position in Cigna Group by 13,333.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,165,408 shares of the health services provider’s stock worth $900,912,000 after purchasing an additional 3,141,844 shares during the period. Dodge & Cox boosted its position in Cigna Group by 19.7% during the fourth quarter. Dodge & Cox now owns 11,138,614 shares of the health services provider’s stock worth $3,065,681,000 after purchasing an additional 1,833,389 shares during the period. Boston Partners increased its stake in shares of Cigna Group by 314.6% in the fourth quarter. Boston Partners now owns 1,638,191 shares of the health services provider’s stock worth $450,856,000 after purchasing an additional 1,243,056 shares in the last quarter. Finally, GQG Partners LLC increased its stake in shares of Cigna Group by 14.3% in the fourth quarter. GQG Partners LLC now owns 7,763,295 shares of the health services provider’s stock worth $2,136,699,000 after purchasing an additional 972,302 shares in the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Buying and Selling at Cigna Group

In related news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total transaction of $268,450.39. Following the completion of the transaction, the chief accounting officer directly owned 2,368 shares in the company, valued at $707,108.48. The trade was a 27.52% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the business’s stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the transaction, the chief executive officer owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. The trade was a 85.46% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several analysts have recently issued reports on CI shares. Guggenheim boosted their price target on shares of Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a research report on Monday, May 4th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. UBS Group boosted their target price on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Wells Fargo & Company increased their target price on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a research report on Friday, May 1st. Finally, Robert W. Baird set a $337.00 price target on Cigna Group in a report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Read Our Latest Research Report on Cigna Group

Cigna Group Stock Performance

Cigna Group stock opened at $303.44 on Wednesday. The firm’s 50 day simple moving average is $286.50 and its 200 day simple moving average is $280.18. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. The firm has a market capitalization of $80.27 billion, a PE ratio of 12.86, a price-to-earnings-growth ratio of 1.17 and a beta of 0.29. Cigna Group has a 1-year low of $239.51 and a 1-year high of $315.47.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, April 30th. The health services provider reported $7.79 EPS for the quarter, beating the consensus estimate of $7.60 by $0.19. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the firm earned $6.74 EPS. The business’s quarterly revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts expect that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, June 18th. Investors of record on Thursday, June 4th were given a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date was Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is 26.45%.

Cigna Group Company Profile

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.